• |
  • |
  • |
  • |
Donate

Product

Long-term safety and efficacy of ganaxolone for the treatment of seizures associated with tuberous sclerosis complex during the extension phase of an open-label phase 2 study.

Center:
Fiscal Year:
2025
Contact Information:
Product Description:
Keyword(s):
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A